Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Long-Term Investments (2019 - 2026)

Vericel (VCEL) posted Long-Term Investments of $102.1 million for Q2 2026, up 0.79% sequentially from $101.3 million in Q1 2026, and up 21.98% YoY from $83.7 million in Q2 2025.

Analysis

Vericel (VCEL) Long-Term Investments (2019 - 2026) Analysis & Trends

Vericel has reported Long-Term Investments for 8 years, with the latest figure at $102.1 million in Q2 2026.

  • Quarterly Long-Term Investments rose 21.98% year-over-year to $102.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $102.1 million (up 21.98% YoY) and the FY2025 annual result came in at $61.4 million, up 53.95% from the prior year.
  • Long-Term Investments improved to $102.1 million in Q2 2026 per VCEL's latest filing, from $101.3 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $102.1 million in Q2 2026 and troughed at $20.0 million in Q4 2022.
  • A 5-year average of $70.0 million and a median of $76.4 million in 2023 frame the typical range for Long-Term Investments.
  • The sharpest annual moves came in 2022 and 2024: Long-Term Investments retreated 22.29% in 2022, then surged 57.73% in 2024.
  • Over 5 years, Long-Term Investments stood at $20.0 million in 2022, then gained by 26.66% to $25.3 million in 2023, then soared by 57.73% to $39.9 million in 2024, then soared by 53.95% to $61.4 million in 2025, then surged by 66.3% to $102.1 million in 2026.
  • According to Business Quant data, Long-Term Investments over the past three periods registered $102.1 million, $101.3 million, and $61.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 5.79 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 9.83 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -4.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 1.77 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 22.17 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 372.10 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn 102.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 102.10 Mn
Mar 31, 2026 101.30 Mn
Dec 31, 2025 61.40 Mn
Sep 30, 2025 84.60 Mn
Jun 30, 2025 83.70 Mn
Mar 31, 2025 82.80 Mn
Dec 31, 2024 39.88 Mn
Sep 30, 2024 80.90 Mn
Jun 30, 2024 78.30 Mn
Mar 31, 2024 77.10 Mn
Dec 31, 2023 25.28 Mn
Sep 30, 2023 65.10 Mn
Jun 30, 2023 75.80 Mn
Mar 31, 2023 77.40 Mn
Dec 31, 2022 19.96 Mn
Sep 30, 2022 67.50 Mn
Jun 30, 2022 68.40 Mn
Mar 31, 2022 67.70 Mn
Dec 31, 2021 25.69 Mn
Sep 30, 2021 64.00 Mn